Concepedia

Patrick Spinazze

PS

Statistics

Publications

13

Citations

395

H-Index

12

Active since

1989

Affiliations

Eli Lilly (United States)(Current)

Bristol-Myers Squibb (United States)

University of Calgary

Patrick Spinazze is an author at Eli Lilly (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1989–2016

13

Publications

13

Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8

Kevin M. Gardinier, Douglas L. Gernert, Warren J. Porter et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +17

Retinoic Acid Receptor β,γ-Selective Ligands: Synthesis and Biological Activity of 6-Substituted 2-Naphthoic Acid Retinoids

Kuo‐Long Yu, Patrick Spinazze, Jacek Ostrowski et al. · Journal of Medicinal Chemistry · 1996 · 56 citations · Full text

, , +16

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 48 citations · Full text

, , +13

Regioselective Preparation of 2,4-, 3,4-, and 2,3,4-Substituted Furan Rings. 1. [1,4] O → C and [1,4] C → O Silyl Migrations of Silyl Ethers and Esters Attached to Furan and Thiophene Rings

Edward J. Bures, Patrick Spinazze, Giovanna Beese et al. · The Journal of Organic Chemistry · 1997 · 38 citations

, , +12

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4

Vincent P. Rocco, Patrick Spinazze, Todd J. Kohn et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 33 citations

, , +13

1–5 of 13